Wesley Green, MD

Specializes In
  • Ophthalmology
Languages Spoken
  • English


Sees Patients For

Cataract and glaucoma surgery

Hospital Affiliations

  • Barnes-Jewish Hospital



Board Certifications

  • Ophthalmology

Academic Title(s)

Instructor of Ophthalmology

Publications & Research

View research profile »


Fellowship: Glaucoma and Advanced Anterior Segment and Cataract Surgery

2018 Washington University, St. Louis, MO

Residency: Ophthalmology

2017 Washington University / Barnes Jewish Hospital, St. Louis, MO

Medical Degree

2013 Chicago Medical School at Rosalind Franklin University of Medicine and Science, IL

Master's Degree: Vision Science

2009 State University of New York College of Optometry, New York, NY

Bachelor's Degree: Biomedical Science

2007 University of Wisconsin - La Crosse, WI

Financial Disclosures
  • EyeCare Partners
    • Additional Disclosures: Outside employment
    • Reporting Date: 05/01/2023

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.